These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24825898)

  • 1. A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis.
    Spencer B; Verma I; Desplats P; Morvinski D; Rockenstein E; Adame A; Masliah E
    J Biol Chem; 2014 Jun; 289(25):17917-31. PubMed ID: 24825898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease.
    Spencer B; Potkar R; Metcalf J; Thrin I; Adame A; Rockenstein E; Masliah E
    J Biol Chem; 2016 Jan; 291(4):1905-1920. PubMed ID: 26620558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain.
    Rofo F; Ugur Yilmaz C; Metzendorf N; Gustavsson T; Beretta C; Erlandsson A; Sehlin D; Syvänen S; Nilsson P; Hultqvist G
    Theranostics; 2021; 11(2):789-804. PubMed ID: 33391505
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease.
    Rose JB; Crews L; Rockenstein E; Adame A; Mante M; Hersh LB; Gage FH; Spencer B; Potkar R; Marr RA; Masliah E
    J Neurosci; 2009 Jan; 29(4):1115-25. PubMed ID: 19176820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
    Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
    Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
    Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
    Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology.
    Fukami S; Watanabe K; Iwata N; Haraoka J; Lu B; Gerard NP; Gerard C; Fraser P; Westaway D; St George-Hyslop P; Saido TC
    Neurosci Res; 2002 May; 43(1):39-56. PubMed ID: 12074840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
    Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
    J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain.
    Iwata N; Mizukami H; Shirotani K; Takaki Y; Muramatsu S; Lu B; Gerard NP; Gerard C; Ozawa K; Saido TC
    J Neurosci; 2004 Jan; 24(4):991-8. PubMed ID: 14749444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function.
    Huang SM; Mouri A; Kokubo H; Nakajima R; Suemoto T; Higuchi M; Staufenbiel M; Noda Y; Yamaguchi H; Nabeshima T; Saido TC; Iwata N
    J Biol Chem; 2006 Jun; 281(26):17941-51. PubMed ID: 16636059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
    Deane R; Singh I; Sagare AP; Bell RD; Ross NT; LaRue B; Love R; Perry S; Paquette N; Deane RJ; Thiyagarajan M; Zarcone T; Fritz G; Friedman AE; Miller BL; Zlokovic BV
    J Clin Invest; 2012 Apr; 122(4):1377-92. PubMed ID: 22406537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.
    Spencer B; Marr RA; Rockenstein E; Crews L; Adame A; Potkar R; Patrick C; Gage FH; Verma IM; Masliah E
    BMC Neurosci; 2008 Nov; 9():109. PubMed ID: 19014502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.
    Marr RA; Rockenstein E; Mukherjee A; Kindy MS; Hersh LB; Gage FH; Verma IM; Masliah E
    J Neurosci; 2003 Mar; 23(6):1992-6. PubMed ID: 12657655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Shuttle Neprilysin reduces central Amyloid-β levels.
    Campos CR; Kemble AM; Niewoehner J; Freskgård PO; Urich E
    PLoS One; 2020; 15(3):e0229850. PubMed ID: 32155191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.
    Guan H; Liu Y; Daily A; Police S; Kim MH; Oddo S; LaFerla FM; Pauly JR; Murphy MP; Hersh LB
    J Neurosci Res; 2009 May; 87(6):1462-73. PubMed ID: 19021293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.